We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
SEB SA | AQEU:SKP | Aquis Europe | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.30 | -1.50% | 85.45 | 85.45 | 85.55 | 86.60 | 85.40 | 86.60 | 4,023 | 16:29:54 |
RNS Number:7227J Skyepharma PLC 07 April 2003 7 April 2003 SkyePharma PLC (the "Company") The SkyePharma PLC 1999 Share Option Scheme (as amended) (the "Scheme") allows the grant of options to employees. On 7 April 2003, 15.8 million share options in total were granted to employees. Under the terms of the Scheme, Executive Directors were granted options to acquire ordinary shares in the Company, at an option price of 46.5 pence per share. The number of options granted to each Executive Director is as follows:- Name Number of Options Ian Gowrie-Smith 1,935,484 Michael Ashton 1,703,226 Donald Nicholson 946,237 These options will only vest and become exercisable subject to the satisfaction of the following conditions:- * continued employment by the relevant Executive Director for the three year performance period from the date of grant; and * the satisfaction of the comparative total shareholder return performance measure. 50% of options will vest for median performance with full vesting only occurring for upper quartile performance (straight line vesting between these two points). - e n d s - This information is provided by RNS The company news service from the London Stock Exchange END RDSSSMFLWSDSEDL
1 Year SEB Chart |
1 Month SEB Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions